The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities

News

The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities

15.07.2020 News

Pfizer and BioNTech shares rose sharply on Monday by 4% and 10%, respectively. This happened after the US Food and Drug Administration (FDA) assigned an “accelerated” status to their two COVID-19 potential vaccines.

Although the companies have not yet completed the final tests and have not received approval for the production and sale of their vaccine, the status gives them a chance to accelerate the transition to these stages. It also gives a chance that their vaccine will receive a FDA “priority review” status, which means that management can decide on approval within six months.

In early July, they said that phase 2 of clinical trials of a vaccine BNT162b1 showed that all 24 volunteers who received two injections had a “strong immune response” to the virus. It was even stronger than that patients who underwent COVID-19 had.

While data on these trials is due to be released this month, today Pfizer and BioNTech intend to move on to testing the most promising of the potential vaccines with up to 30,000 participants in the United States and Europe.

“The FDA’s decision to grant these two COVID-19 vaccines an ‘accelerated status’ is an important milestone in efforts to develop a safe and effective SARS-CoV-2 vaccine,” said Peter Honig, Pfizer’s Senior Vice President of global regulation. “We look forward to continuing to work closely with the FDA throughout the clinical development of this Project Lightspeed program to evaluate the safety and efficiency of these vaccines.”

According to Pfizer, if regulators eventually approve the drug, Pfizer and BioNTech will deliver up to 100 million doses by the end of the year and at least another 1.2 billion by the end of 2021.

Moderna which is developing a potential vaccine using technology similar to Pfizer and BioNTech received the same “accelerated” status in May for its COVID-19 vaccine candidate.

Moderna shares jumped 14.65% on Monday because of the news that they will be added to the Nasdaq-100 index before the market opens on July 20.

Analysts estimate the potential annual revenue from global COVID-19 vaccine sales at $5 to $10 billion.

Other articles

  • Канада схвалила використання COVID-вакцини від Pfizer
    News

    Канада схвалила використання COVID-вакцини від Pfizer

    Міністерство охорони здоров’я Канади схвалило використання вакцини від коронавірусної інфекції компаній Pfizer і BioNTech, оскільки препарат “відповідає найсуворішим вимогам безпеки, ефективності та якості”, пише ТАСС з посиланням на сайт відомства. Зазначається, що в розділі Вакцинація від коронавірусу навпроти даних про вакцину Pfizer/BioNTech стоїть напис: “Схвалено 9 грудня 2020 року”. У МОЗ підкреслили, що спочатку фахівці […]

  • Pfizer will deliver half of the planned number of vaccines in 2020
    News

    Pfizer will deliver half of the planned number of vaccines in 2020

    Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]

  • Sinovac Biotech залучила $500 млн для виробництва вакцини від COVID-19
    News

    Sinovac Biotech залучила $500 млн для виробництва вакцини від COVID-19

    Китайський розробник і виробник вакцини проти COVID-19 Sinovac Biotech оголосив у понеділок про продаж 15% в своєму підрозділі Sinovac Life Sciences. Частка продана одному з найбільших в Китаї виробників дженериків Sino Biopharmaceutical приблизно за $500 млн. Тим самим, як повідомила компанія, Sinovac забезпечила себе засобами, необхідними для виробництва вакцини CoronaVac. Домовленість щодо угоди була досягнута […]

  • Moderna має намір випустити 145 млн доз вакцини від COVID-19 до кінця березня
    News

    Moderna має намір випустити 145 млн доз вакцини від COVID-19 до кінця березня

    Американська біотехнологічна компанія, сфокусована на розробці ліків і вакцин, розкрила нові подробиці про очікувані постачання своєї вакцини від COVID-19. Так, компанія зможе надати вакцини для імунізації до 60 мільйонів осіб в США і 12,5 мільйона за межами країни до кінця березня, пише The Wall Street Journal. Представники Moderna заявили, що в цьому місяці збираються в […]

  • Moderna vaccine will be tested on teenagers
    News

    Moderna vaccine will be tested on teenagers

    The mRNA-1273 vaccine from the American company Moderna will be tested on three thousand children in six US states. CNN reported this on Wednesday, December 2. “Moderna has started inviting children over the age of 12 to try the vaccine” the statement said. It is noted that the study will involve volunteers aged 12-18 from […]

  • Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19
    News

    Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19

    Following the third phase of trials of its COVID-19 coronavirus vaccine, Moderna said the drug was generally well tolerated and no serious health problems were identified. According to the company, the effectiveness of its vaccine reaches 94.1%, and 100% for preventing severe coronavirus cases. Previously, the manufacturer estimated the effectiveness of its drug at 94.5%. […]

  • Єврокомісія закупить вакцину Moderna
    News

    Єврокомісія закупить вакцину Moderna

    Європейська комісія (ЄК) повідомила, що схвалила шостий контракт в рамках стратегії Євросоюзу щодо вакцин проти коронавірусу. Це контракт з американською фармацевтичною компанією Moderna, його сума не називається. За умовами угоди спочатку ЄС закупить 80 млн доз і зможе запросити ще стільки ж після того, як буде доведена ефективність і безпека вакцини. «Я дуже рада оголосити […]

  • МОЗ домовляється з шістьма компаніями про вакцину
    News

    МОЗ домовляється з шістьма компаніями про вакцину

    МОЗ веде переговори з шістьма компаніями з постачання вакцини від COVID-19 в Україні. Про це заявив глава МОЗ Максим Степанов. Зараз Україна веде переговори з усіма виробниками вакцини від коронавірусу, так як за рахунок однієї компанії МОЗ не зможе забезпечити вакциною все населення країни, говорить міністр. “Ми вже на етапі підписання відповідних документів. Це компанія […]

Read also

AXA Granola with Nuts Image
News

MEET NEW NUTTY ENJOYMENT FROM AXA

Good news from products company Lantmannen AXA was not long in coming! Company asked consumers: “What ingredients do you add most often to granola?” One of the most popular answers is nuts. We launched Super nuts Granola! The design has acquired the corporate style of the AXA Granola line. In combination with oatmeal, crispy honey […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Diageo accused LVMH of not paying dividends of 181 million euros

The world’s largest producer of alcohol, the British Diageo has initiated arbitration proceedings with the French luxury goods manufacturer LVMH Moet Hennessy – Louis Vuitton SA due to non-payment of dividends in the amount of 181 million euros in 2019. Diageo owns 34% in the joint venture with LVMH for the production of alcoholic beverages […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

The USA court has forbidden the UMH to use the brand “Forbes”

International Court of Arbitration in New York in a dispute between the  UMH – the Ukrainian publisher of “Forbes Ukraine” magazine,  and the Forbes Media, LLC American publishing house ruled in favor of the latter on April, 20, and revoked the license of Forbes Ukraine, said in Forbes Media, LLC  to the publication LІGA.net UMH […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Ukrainians Begin Receiving Record National Cashback Payments

Ukrainian citizens have started receiving National Cashback payments for August, which have reached a record amount since the program’s launch, according to the press service of the Diia app. The total payout amounted to ₴509 million, distributed among more than 3.6 million Ukrainians. These are funds citizens earned by purchasing domestically made goods — in […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

AMD introduced its new processors as the “fastest gaming processor in the world”

On Thursday, Advanced Micro Devices Inc. has introduced the long-awaited line of four next-generation Ryzen 5000 series CPUs for the desktop PCs, based on the new Zen 3 architecture. Ryzen 5000 series products are based on the 7-nm manufacturing process of the Taiwan Semiconductor and designed for the computer gamers and the content creators. AMD […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

About 2,500 Boeing 737s will be tested for malfunction

The US Federal Aviation Administration (FAA) has ordered the state airline to inspect about 2,500 Boeing 737 aircraft for defective relays and cabin pressure drops. “An undetected failure of both relays could slow the crew’s detection of insufficient cabin pressure and result in the crew losing their ability to work due to hypoxia and, as […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

EBRD Downgrades Ukraine’s GDP Growth Forecast

The European Bank for Reconstruction and Development (EBRD) has revised down its forecast for Ukraine’s real GDP growth in 2025 from 3.3% to 2.5%, while keeping its 2026 forecast unchanged at 5.0%, conditional on the end of the war with Russia. The update was published in the EBRD’s latest economic report. “Ukraine’s GDP growth is […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

For purchase of the vaccines COVID-19 will be allocated 2.6 billion UAH

Ukraine will allocate 2.6 billion hryvnias for the purchase of a coronavirus vaccine. This was stated by Finance Minister Serhiy Marchenko at the press conference on Monday, September 14. “By 2023, we have a real opportunity to ensure health care spending at 5%. There is an increase in 2021 to 4.2% of GDP for health […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

OnlyFans owner receives record dividends

OnlyFans owner Leonid Radvinsky has received record dividends of $701 million, Bloomberg reports. The record payout was revealed in filings from London-based Fenix International Ltd., which operates the platform, amid speculation about a possible sale of the business valued at up to $8 billion. As of the end of 2024, transactions on the platform reached […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

The AMCU allowed the NAP II Holdings to buy more than 50% of the shares in two agricultural companies

Recently, the Antimonopoly Committee of Ukraine allowed the company NAP II Holdings B.V. (Netherlands), controlled by  the NCH Capital (USA) to acquire more than 50% of the shares of two agricultural enterprises in the Khmelnitskyi region. This is stated on the AMCU  website. The permission granted for the purchase of the  shares of the companies […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Russia Selling Gas to China at a 40% Discount

This year, Russia is selling gas to China at a nearly 40% discount, according to The Moscow Times, citing data from Russia’s Ministry of Economic Development. In the ministry’s baseline forecast, the average price of Russian gas for exports to distant foreign markets (excluding China)—namely Turkey and the remaining European countries—will amount to $356.7 per […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

“Epicenter” is accused of unfair competition and pressure on suppliers

The owner of the largest online store Rozetka.ua,  Vladislav Chechetkin accused the retailer “Epicenter” which is developing a network of building supermarkets, in the non-competitive behavior and pressure on suppliers. “Epicenter” for a long time, probably two years, requires the suppliers not to sell the goods in Rozetka.ua. This solicitation sounds like: if your product […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

One of the most popular taxi service in the world Uber is preparing to start in Ukraine

According to the preliminary information, the official start of the Uber in Ukraine will take place in Kiev in the first quarter of this year and perhaps in Lviv. As told L?GA.net consultant on site Uberlin (the mediator of the company), a preliminary recruitment  of drivers is opened. “Our company has experience with Uber in […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

The UN has estimated the scale of the decline in world trade in 2020

Global trade turnover in 2020 will decrease by 7-9%. This was announced on Wednesday, October 21, by the RBC-Ukraine news agency with reference to the report of the UN Conference on Trade and Development UNCTAD. The decline in trade has occurred in all regions of the world due to quarantine restrictions, the report said. They […]

Next
The Vaccine From Pfizer and BioNTech Receives Status “Accelerated” From The Regulatory Authorities
News

Investors plan to reorganize the management of Volkswagen

In December, Volkswagen expects more changes. December 7, 2015 the company went to Qatar, where they had meeting with one of its main investors, Qatar Investment Authority. Volkswagen representative Eric Felber pointed out that the visit is devoted to restructuring and improving the management and the most important shareholders should express their opinion on this […]

Next
KtRrrVz3 l
News

FIS Integrates into Visa B2B Connect Platform

Participating FIS client banks will be able to send and receive large-ticket international corporate payments quickly and securely KYIV – May 15, 2019 – Visa Inc. (NYSE:V) and FIS are joining forces to enable FIS’ commercial financial institution clients to quickly and securely access the Visa B2B Connect platform globally*. Visa B2B Connect will be […]

Next
WP2Social Auto Publish Powered By : XYZScripts.com